STROKE:对Moyamoya病患者来说,做个EC-IC旁路重建术会累及认知功能吗?

2017-06-14 shaosai MedSci原创

采用EC-IC旁路进行脑实质血运重建技术被广泛用于治疗moyamoya病,但该手术对患者认知的影响是尚不明确。

采用EC-IC旁路进行脑实质血运重建技术被广泛用于治疗moyamoya病,但该手术对患者认知的影响是尚不明确。 近期,研究人员在心血管权威杂志Stroke上发表一项研究成果,采用神经认知量表,分析Moyamoya病患者手术前后认知能力的变化,进而评估该术式对患者认知功能影响的情况。


在该研究中,采用了一种结构化的神经认知量表系统,对患有Moyamoya病的病人在术前及术后6个月进行认知能力的评估。对于每一项测试,都采用可靠变化指数来进行结果分析,以最大程度地较少重测的变异以及操作产生的偏倚。

研究人员经对实验数据分析得出,本研究人群中有12例(14%)术后认知能力显着下降,9例(11%)认知功能得到改善,63例(75%)认知功能并无明显变化。 当分析仅限于单侧(33例)或双侧(51例)血运重建的患者时,实验结果并无明显变化。

因此,研究表明大多数患者在EC-IC旁路手术后,神经认知功能并无显着性下降或改善。在Moyamoya病人群中,简易的EC-IC旁路似乎不能作为患者认知能力受损的风险因素。

原始出处:

Zeifert PD 1, Karzmark P 1, Bell-Stephens TE 1, et al. Neurocognitive Performance After Cerebral Revascularization in Adult Moyamoya Disease. Stroke. 2017. DOI: 10.1161/STROKEAHA.116.016028

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1700275, encodeId=a33e1e002753b, content=<a href='/topic/show?id=50331215910' target=_blank style='color:#2F92EE;'>#Moyamoya病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12159, encryptionId=50331215910, topicName=Moyamoya病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96f30025701, createdName=jj000011, createdTime=Mon Dec 04 09:04:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217134, encodeId=2bdd21e13472, content=好好学习,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLANEL7Sww3HicKsN9aribicAmGGWXOIMEiaZ1iadgZg9RibjqSwIKUS8gSPib2NwTVg2zVvVJhdP3BkuDIl/0, createdBy=944d1605392, createdName=shaosai, createdTime=Fri Jun 30 18:04:37 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210961, encodeId=8650210961c1, content=多谢分享,好东西!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLANEL7Sww3HicKsN9aribicAmGGWXOIMEiaZ1iadgZg9RibjqSwIKUS8gSPib2NwTVg2zVvVJhdP3BkuDIl/0, createdBy=944d1605392, createdName=shaosai, createdTime=Thu Jun 15 07:14:33 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1700275, encodeId=a33e1e002753b, content=<a href='/topic/show?id=50331215910' target=_blank style='color:#2F92EE;'>#Moyamoya病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12159, encryptionId=50331215910, topicName=Moyamoya病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96f30025701, createdName=jj000011, createdTime=Mon Dec 04 09:04:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217134, encodeId=2bdd21e13472, content=好好学习,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLANEL7Sww3HicKsN9aribicAmGGWXOIMEiaZ1iadgZg9RibjqSwIKUS8gSPib2NwTVg2zVvVJhdP3BkuDIl/0, createdBy=944d1605392, createdName=shaosai, createdTime=Fri Jun 30 18:04:37 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210961, encodeId=8650210961c1, content=多谢分享,好东西!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLANEL7Sww3HicKsN9aribicAmGGWXOIMEiaZ1iadgZg9RibjqSwIKUS8gSPib2NwTVg2zVvVJhdP3BkuDIl/0, createdBy=944d1605392, createdName=shaosai, createdTime=Thu Jun 15 07:14:33 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
    2017-06-30 shaosai

    好好学习,涨知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1700275, encodeId=a33e1e002753b, content=<a href='/topic/show?id=50331215910' target=_blank style='color:#2F92EE;'>#Moyamoya病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12159, encryptionId=50331215910, topicName=Moyamoya病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f96f30025701, createdName=jj000011, createdTime=Mon Dec 04 09:04:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217134, encodeId=2bdd21e13472, content=好好学习,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLANEL7Sww3HicKsN9aribicAmGGWXOIMEiaZ1iadgZg9RibjqSwIKUS8gSPib2NwTVg2zVvVJhdP3BkuDIl/0, createdBy=944d1605392, createdName=shaosai, createdTime=Fri Jun 30 18:04:37 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210961, encodeId=8650210961c1, content=多谢分享,好东西!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLANEL7Sww3HicKsN9aribicAmGGWXOIMEiaZ1iadgZg9RibjqSwIKUS8gSPib2NwTVg2zVvVJhdP3BkuDIl/0, createdBy=944d1605392, createdName=shaosai, createdTime=Thu Jun 15 07:14:33 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
    2017-06-15 shaosai

    多谢分享,好东西!

    0